VIVO - Meridian Bioscience, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
14.90
+0.55 (+3.83%)
As of 2:32PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close14.30
Open14.40
Bid14.85 x 300
Ask14.90 x 300
Day's Range14.20 - 14.95
52 Week Range13.23 - 16.45
Volume121,501
Avg. Volume291,262
Market Cap630.385M
Beta0.69
PE Ratio (TTM)29.22
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.50 (3.47%)
Ex-Dividend Date2018-02-02
1y Target EstN/A
Trade prices are not sourced from all markets
  • Associated Press4 hours ago

    Meridian Bioscience: Fiscal 2Q Earnings Snapshot

    On a per-share basis, the Cincinnati-based company said it had net income of 12 cents. Earnings, adjusted for non-recurring costs, came to 21 cents per share. The results exceeded Wall Street expectations. ...

  • Top NasdaqGS Healthcare Dividend Paying Companies
    Simply Wall St.2 months ago

    Top NasdaqGS Healthcare Dividend Paying Companies

    The healthcare sector has a higher prevalence of companies with sustainable competitive advantages compared to other sectors which implies it may continue generating robust excess returns. When the economy isRead More...

  • Associated Press3 months ago

    Meridian Bioscience beats 1Q profit forecasts

    On a per-share basis, the Cincinnati-based company said it had net income of 15 cents. The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment ...

  • American City Business Journals3 months ago

    Greater Cincinnati firm faces lawsuits linked to FDA warning, stock dip

    The value of the stock shifted after a division of Greater Cincinnati’s 25th-largest public company was cited for alleged violations by a federal agency. The FDA noted that it had issued an advisory to the public in May that Magellan’s LeadCare test systems performed on blood drawn from a vein might provide low results that were erroneous.

  • Capital Cube4 months ago

    Meridian Bioscience, Inc. :VIVO-US: Earnings Analysis: Q4, 2017 By the Numbers : December 11, 2017

    Categories: Yahoo FinanceGet free summary analysis Meridian Bioscience, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Meridian Bioscience, Inc. – Quidel Corporation, Hologic, Inc., Thermo Fisher Scientific Inc., Becton, Dickinson and Company and Oxford Immunotec Global PLC (QDEL-US, HOLX-US, TMO-US, BDX-US and OXFD-US) that ... Read more (Read more...)

  • Meridian Bioscience, Inc. :VIVO-US: Earnings Analysis: 2017 By the Numbers : December 1, 2017
    Capital Cube5 months ago

    Meridian Bioscience, Inc. :VIVO-US: Earnings Analysis: 2017 By the Numbers : December 1, 2017

    Categories: Yahoo FinanceGet free summary analysis Meridian Bioscience, Inc. reports financial results for the year ended September 30, 2017. We analyze the earnings along side the following peers of Meridian Bioscience, Inc. – Quidel Corporation, Hologic, Inc., Becton, Dickinson and Company, Thermo Fisher Scientific Inc. and Oxford Immunotec Global PLC (QDEL-US, HOLX-US, BDX-US, TMO-US and OXFD-US) that ... Read more (Read more...)

  • GuruFocus.com5 months ago

    Meridian Bioscience Inc (VIVO) Files 10-K for the Fiscal Year Ended on September 30, 2017

    Meridian Bioscience Inc (NASDAQ:VIVO) files its latest 10-K with SEC for the fiscal year ended on September 30, 2017.

  • Meridian Bioscience, Inc. breached its 50 day moving average in a Bearish Manner : VIVO-US : November 28, 2017
    Capital Cube5 months ago

    Meridian Bioscience, Inc. breached its 50 day moving average in a Bearish Manner : VIVO-US : November 28, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Meridian Bioscience, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish ... Read more (Read more...)

  • Only 3 Days Left To Cash In On Meridian Bioscience Inc (VIVO) Dividend, Is It Worth Buying?
    Simply Wall St.5 months ago

    Only 3 Days Left To Cash In On Meridian Bioscience Inc (VIVO) Dividend, Is It Worth Buying?

    Have you been waiting for Meridian Bioscience Inc’s (NASDAQ:VIVO) upcoming dividend of $0.13 per share? Then you only have to wait 3 more days before the stock pays out onRead More...

  • Associated Press6 months ago

    Meridian Bioscience meets 4Q profit forecasts

    On a per-share basis, the Cincinnati-based company said it had net income of 13 cents. Earnings, adjusted for non-recurring costs, came to 15 cents per share. The results met Wall Street expectations. ...

  • Capital Cube6 months ago

    Meridian Bioscience, Inc. – Value Analysis (NASDAQ:VIVO) : November 6, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Meridian Bioscience, Inc. a score of 75. Our analysis is based on comparing Meridian Bioscience, Inc. with the following peers – Quidel Corporation, ERBA Diagnostics, Inc., Hologic, Inc., Becton, Dickinson and Company, Thermo Fisher Scientific Inc., BG Medicine, Inc. and Oxford Immunotec Global PLC (QDEL-US, ERBA-US, HOLX-US, ... Read more (Read more...)

  • Reuters6 months ago

    UPDATE 2-FDA warns Meridian of violations for lead-testing devices

    The U.S. Food and Drug Administration said on Monday it issued a warning letter to Meridian Bioscience Inc's unit for several federal law violations after inspecting its facility that makes lead-testing devices. The violations include selling significantly modified versions of two of its blood lead-testing systems without the FDA's approval and failing to submit reports on the medical device after customer complained about discrepancies in the test results. The U.S. regulator in July issued Meridian's unit, Magellan Diagnostics, a Form 483 for its North Billerica, Massachusetts-based facility, nearly two months after it warned that the tests may underestimate lead levels in blood.

  • American City Business Journals6 months ago

    Stock in Cincinnati firm dips after FDA warning

    Stock in Meridian Bioscience Inc. dropped nearly 4 percent in trading Monday after a division of the company was cited for alleged violations by a federal agency. The LeadCare Testing Systems detect the amount of lead in a blood sample obtained from finger or heel prick or from a vein. The systems are used in clinical laboratories, doctor’s offices, clinics and hospitals throughout the United States.

  • American City Business Journals6 months ago

    One of Cincinnati’s largest public companies names new CEO

    One of the largest public companies in Greater Cincinnati has a new leader. John “Jack” Kenny was named CEO of Meridian Biosience Inc. (VIVO) effective Oct. 9, the company announced. Kenny’s appointment follows the company’s succession plan that was released earlier this year and comes after several months of searching for its next top executive.

  • Capital Cube6 months ago

    ETFs with exposure to Meridian Bioscience, Inc. : October 11, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Meridian Bioscience, Inc. Here are 5 ETFs with the largest exposure to VIVO-US. Comparing the performance and risk of Meridian Bioscience, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Meridian Bioscience, Inc. breached its 50 day moving average in a Bullish Manner : VIVO-US : September 25, 2017
    Capital Cube7 months ago

    Meridian Bioscience, Inc. breached its 50 day moving average in a Bullish Manner : VIVO-US : September 25, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Meridian Bioscience, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish ... Read more (Read more...)

  • Meridian Bioscience, Inc. breached its 50 day moving average in a Bullish Manner : VIVO-US : September 14, 2017
    Capital Cube7 months ago

    Meridian Bioscience, Inc. breached its 50 day moving average in a Bullish Manner : VIVO-US : September 14, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Meridian Bioscience, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish ... Read more (Read more...)

  • Capital Cube8 months ago

    ETFs with exposure to Meridian Bioscience, Inc. : August 28, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Meridian Bioscience, Inc. Here are 5 ETFs with the largest exposure to VIVO-US. Comparing the performance and risk of Meridian Bioscience, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Meridian Bioscience, Inc. :VIVO-US: Earnings Analysis: Q3, 2017 By the Numbers : August 21, 2017
    Capital Cube8 months ago

    Meridian Bioscience, Inc. :VIVO-US: Earnings Analysis: Q3, 2017 By the Numbers : August 21, 2017

    Categories: Yahoo FinanceGet free summary analysis Meridian Bioscience, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Meridian Bioscience, Inc. – Alere Inc., Quidel Corporation, Hologic, Inc., Becton, Dickinson and Company, Thermo Fisher Scientific Inc. and Oxford Immunotec Global PLC (ALR-US, QDEL-US, HOLX-US, BDX-US, TMO-US ... Read more (Read more...)

  • Meridian (VIVO) Initiates illumigene CMV Trial, Shares Shine
    Zacks9 months ago

    Meridian (VIVO) Initiates illumigene CMV Trial, Shares Shine

    Solid share price rally following the news suggests that the latest development is likely to buoy Meridian's (VIVO) bottom line and enhance its illumigene platform.

  • Associated Press9 months ago

    Meridian Bioscience meets 3Q profit forecasts

    The Cincinnati-based company said it had profit of 1 cent per share. Earnings, adjusted for asset impairment costs, came to 16 cents per share. The results met Wall Street expectations. The average estimate ...